Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M., Hussain, A., Rehman, M., . . . Hassan, M. (2020). Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy. Biosci Rep.

Shamsi, Anas, Taj Mohammad, Saleha Anwar, Mohamed F AlAjmi, Afzal Hussain, Md. Tabish Rehman, Asimul Islam, and Md. Imtaiyaz Hassan. "Glecaprevir and Maraviroc Are High-affinity Inhibitors of SARS-CoV-2 Main Protease: Possible Implication in COVID-19 Therapy." Biosci Rep 2020.

Shamsi, Anas, et al. "Glecaprevir and Maraviroc Are High-affinity Inhibitors of SARS-CoV-2 Main Protease: Possible Implication in COVID-19 Therapy." Biosci Rep 2020.